Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Hansen Scott G."" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-9 z 9
    Tytuł:
    In vitro and in vivo characterization of a recombinant rhesus cytomegalovirus containing a complete genome.
    Autorzy:
    Taher H; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
    Mahyari E; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.; Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Oregon, United States of America.
    Kreklywich C; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
    Uebelhoer LS; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
    McArdle MR; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
    Moström MJ; Tulane National Primate Research Center, Tulane University, Covington, Louisiana, United States of America.
    Bhusari A; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
    Nekorchuk M; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.; Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Oregon, United States of America.
    E X; Department of Microbiology and Physiological Systems, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America.
    Whitmer T; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
    Scheef EA; Tulane National Primate Research Center, Tulane University, Covington, Louisiana, United States of America.
    Sprehe LM; Tulane National Primate Research Center, Tulane University, Covington, Louisiana, United States of America.
    Roberts DL; Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, United Kingdom.
    Hughes CM; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
    Jackson KA; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
    Selseth AN; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
    Ventura AB; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
    Cleveland-Rubeor HC; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
    Yue Y; Center for Comparative Medicine and Department of Medical Pathology, University of California, Davis, California, United States of America.
    Schmidt KA; Center for Comparative Medicine and Department of Medical Pathology, University of California, Davis, California, United States of America.
    Shao J; Statistical Center for HIV/AIDS Research and Prevention, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
    Edlefsen PT; Statistical Center for HIV/AIDS Research and Prevention, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
    Smedley J; Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Oregon, United States of America.
    Kowalik TF; Department of Microbiology and Physiological Systems, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America.
    Stanton RJ; Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, United Kingdom.
    Axthelm MK; Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Oregon, United States of America.
    Estes JD; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.; Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Oregon, United States of America.
    Hansen SG; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
    Kaur A; Tulane National Primate Research Center, Tulane University, Covington, Louisiana, United States of America.
    Barry PA; Center for Comparative Medicine and Department of Medical Pathology, University of California, Davis, California, United States of America.
    Bimber BN; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.; Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Oregon, United States of America.
    Picker LJ; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
    Streblow DN; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
    Früh K; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
    Malouli D; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
    Pokaż więcej
    Źródło:
    PLoS pathogens [PLoS Pathog] 2020 Nov 24; Vol. 16 (11), pp. e1008666. Date of Electronic Publication: 2020 Nov 24 (Print Publication: 2020).
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Viremia*
    Cytomegalovirus/*genetics
    Cytomegalovirus Infections/*virology
    Genome, Viral/*genetics
    Animals ; Cell Line ; Chromosomes, Artificial, Bacterial ; Cytomegalovirus/pathogenicity ; DNA, Recombinant ; Disease Models, Animal ; Female ; Fibroblasts/virology ; Humans ; Macaca mulatta ; Male ; Mutation ; Open Reading Frames/genetics ; Phylogeny ; Species Specificity
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Modulation of MHC-E transport by viral decoy ligands is required for RhCMV/SIV vaccine efficacy.
    Autorzy:
    Verweij MC; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
    Hansen SG; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
    Iyer R; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
    John N; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
    Malouli D; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
    Morrow D; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
    Scholz I; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
    Womack J; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
    Abdulhaqq S; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
    Gilbride RM; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
    Hughes CM; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
    Ventura AB; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
    Ford JC; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
    Selseth AN; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
    Oswald K; AIDS and Cancer Virus Program, Frederick National Laboratory, Frederick, MD 21702, USA.
    Shoemaker R; AIDS and Cancer Virus Program, Frederick National Laboratory, Frederick, MD 21702, USA.
    Berkemeier B; AIDS and Cancer Virus Program, Frederick National Laboratory, Frederick, MD 21702, USA.
    Bosche WJ; AIDS and Cancer Virus Program, Frederick National Laboratory, Frederick, MD 21702, USA.
    Hull M; AIDS and Cancer Virus Program, Frederick National Laboratory, Frederick, MD 21702, USA.
    Shao J; Population Sciences and Computational Biology Programs, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
    Sacha JB; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
    Axthelm MK; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
    Edlefsen PT; Population Sciences and Computational Biology Programs, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
    Lifson JD; AIDS and Cancer Virus Program, Frederick National Laboratory, Frederick, MD 21702, USA.
    Picker LJ; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA. .
    Früh K; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA. .
    Pokaż więcej
    Źródło:
    Science (New York, N.Y.) [Science] 2021 Apr 30; Vol. 372 (6541). Date of Electronic Publication: 2021 Mar 25.
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
    MeSH Terms:
    CD8-Positive T-Lymphocytes/*immunology
    Cytomegalovirus/*metabolism
    Genetic Vectors/*metabolism
    Histocompatibility Antigens Class I/*metabolism
    Peptide Fragments/*metabolism
    SAIDS Vaccines/*immunology
    Animals ; Cell Line ; Cytomegalovirus/genetics ; Epitopes, T-Lymphocyte/immunology ; Fibroblasts/metabolism ; Genetic Vectors/genetics ; Histocompatibility Antigens Class I/genetics ; Ligands ; Macaca mulatta ; Peptide Fragments/genetics ; Protein Transport ; Simian Immunodeficiency Virus ; HLA-E Antigens
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Characterization of a live-attenuated HCMV-based vaccine platform.
    Autorzy:
    Caposio P; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, 97006, USA.
    van den Worm S; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, 97006, USA.; Batavia Biosciences B.V., Zernikedreef 16, 2333 CL, Leiden, Netherlands.
    Crawford L; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, 97006, USA.
    Perez W; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, 97006, USA.
    Kreklywich C; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, 97006, USA.
    Gilbride RM; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, 97006, USA.
    Hughes CM; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, 97006, USA.
    Ventura AB; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, 97006, USA.
    Ratts R; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, 97006, USA.; Vir Biotechnology, 4640, SW Macadam Avenue, Portland, OR, 97239, USA.
    Marshall EE; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, 97006, USA.; Vir Biotechnology, 4640, SW Macadam Avenue, Portland, OR, 97239, USA.
    Malouli D; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, 97006, USA.
    Axthelm MK; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, 97006, USA.
    Streblow D; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, 97006, USA.
    Nelson JA; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, 97006, USA.
    Picker LJ; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, 97006, USA.
    Hansen SG; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, 97006, USA. .
    Früh K; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, 97006, USA. .
    Pokaż więcej
    Źródło:
    Scientific reports [Sci Rep] 2019 Dec 17; Vol. 9 (1), pp. 19236. Date of Electronic Publication: 2019 Dec 17.
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Cytomegalovirus*/genetics
    Cytomegalovirus*/immunology
    Cytomegalovirus Infections*/genetics
    Cytomegalovirus Infections*/immunology
    Cytomegalovirus Infections*/prevention & control
    Cytomegalovirus Vaccines*/genetics
    Cytomegalovirus Vaccines*/immunology
    Animals ; Cell Line, Tumor ; Human Umbilical Vein Endothelial Cells ; Humans ; Mice ; Mice, Inbred NOD ; Vaccines, Attenuated/genetics ; Vaccines, Attenuated/immunology
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Cytomegalovirus vectors expressing Plasmodium knowlesi antigens induce immune responses that delay parasitemia upon sporozoite challenge.
    Autorzy:
    Hansen SG; Oregon Health & Science University, Vaccine & Gene Therapy Institute, Beaverton, OR, United States of America.; Oregon Health & Science University, Oregon National Primate Research Center, Beaverton, OR, United States of America.
    Womack J; Oregon Health & Science University, Vaccine & Gene Therapy Institute, Beaverton, OR, United States of America.
    Scholz I; Oregon Health & Science University, Vaccine & Gene Therapy Institute, Beaverton, OR, United States of America.
    Renner A; US Military Malaria Vaccine Program, Naval Medical Research Center, Silver Spring, MD, United States of America.
    Edgel KA; US Military Malaria Vaccine Program, Naval Medical Research Center, Silver Spring, MD, United States of America.
    Xu G; Oregon Health & Science University, Vaccine & Gene Therapy Institute, Beaverton, OR, United States of America.
    Ford JC; Oregon Health & Science University, Vaccine & Gene Therapy Institute, Beaverton, OR, United States of America.
    Grey M; Oregon Health & Science University, Vaccine & Gene Therapy Institute, Beaverton, OR, United States of America.
    St Laurent B; National Institutes of Health, Laboratory of Malaria and Vector Research, Malaria Pathogenesis and Human Immunity Unit, Rockville, MD, United States of America.
    Turner JM; Oregon Health & Science University, Oregon National Primate Research Center, Beaverton, OR, United States of America.
    Planer S; Oregon Health & Science University, Oregon National Primate Research Center, Beaverton, OR, United States of America.
    Legasse AW; Oregon Health & Science University, Oregon National Primate Research Center, Beaverton, OR, United States of America.
    Richie TL; US Military Malaria Vaccine Program, Naval Medical Research Center, Silver Spring, MD, United States of America.
    Aguiar JC; US Military Malaria Vaccine Program, Naval Medical Research Center, Silver Spring, MD, United States of America.
    Axthelm MK; Oregon Health & Science University, Vaccine & Gene Therapy Institute, Beaverton, OR, United States of America.; Oregon Health & Science University, Oregon National Primate Research Center, Beaverton, OR, United States of America.
    Villasante ED; US Military Malaria Vaccine Program, Naval Medical Research Center, Silver Spring, MD, United States of America.
    Weiss W; US Military Malaria Vaccine Program, Naval Medical Research Center, Silver Spring, MD, United States of America.
    Edlefsen PT; Statistical Center for HIV/AIDS Research and Prevention, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America.
    Picker LJ; Oregon Health & Science University, Vaccine & Gene Therapy Institute, Beaverton, OR, United States of America.; Oregon Health & Science University, Oregon National Primate Research Center, Beaverton, OR, United States of America.
    Früh K; Oregon Health & Science University, Vaccine & Gene Therapy Institute, Beaverton, OR, United States of America.; Oregon Health & Science University, Oregon National Primate Research Center, Beaverton, OR, United States of America.
    Pokaż więcej
    Źródło:
    PloS one [PLoS One] 2019 Jan 23; Vol. 14 (1), pp. e0210252. Date of Electronic Publication: 2019 Jan 23 (Print Publication: 2019).
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
    MeSH Terms:
    Antigens, Protozoan/*immunology
    Cytomegalovirus/*genetics
    Malaria/*immunology
    Malaria Vaccines/*immunology
    Parasitemia/*immunology
    Plasmodium knowlesi/*immunology
    Sporozoites/*immunology
    Animals ; Anopheles/immunology ; Anopheles/parasitology ; Female ; Genetic Vectors/administration & dosage ; Immunologic Memory ; Liver/immunology ; Liver/parasitology ; Macaca mulatta ; Malaria/blood ; Malaria/parasitology ; Malaria/prevention & control ; Male ; Parasitemia/blood ; Parasitemia/parasitology ; Parasitemia/prevention & control ; Plasmodium knowlesi/genetics ; Protozoan Proteins/immunology ; T-Lymphocytes/immunology ; T-Lymphocytes/parasitology
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Natural Killer Cell Evasion Is Essential for Infection by Rhesus Cytomegalovirus.
    Autorzy:
    Sturgill ER; Vaccine and Gene Therapy Institute, Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Oregon, United States of America.
    Malouli D; Vaccine and Gene Therapy Institute, Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Oregon, United States of America.
    Hansen SG; Vaccine and Gene Therapy Institute, Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Oregon, United States of America.
    Burwitz BJ; Vaccine and Gene Therapy Institute, Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Oregon, United States of America.
    Seo S; Vaccine and Gene Therapy Institute, Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Oregon, United States of America.
    Schneider CL; Department of Life Sciences, Carroll University, Waukesha, Wisconsin, United States of America.
    Womack JL; Vaccine and Gene Therapy Institute, Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Oregon, United States of America.
    Verweij MC; Vaccine and Gene Therapy Institute, Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Oregon, United States of America.
    Ventura AB; Vaccine and Gene Therapy Institute, Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Oregon, United States of America.
    Bhusari A; Vaccine and Gene Therapy Institute, Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Oregon, United States of America.
    Jeffries KM; Vaccine and Gene Therapy Institute, Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Oregon, United States of America.
    Legasse AW; Vaccine and Gene Therapy Institute, Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Oregon, United States of America.
    Axthelm MK; Vaccine and Gene Therapy Institute, Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Oregon, United States of America.
    Hudson AW; Department of Microbiology and Molecular Genetics, Medical College of Wisconsin, Milwaukee, Wisconsin, United States of America.
    Sacha JB; Vaccine and Gene Therapy Institute, Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Oregon, United States of America.
    Picker LJ; Vaccine and Gene Therapy Institute, Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Oregon, United States of America.
    Früh K; Vaccine and Gene Therapy Institute, Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Oregon, United States of America.
    Pokaż więcej
    Źródło:
    PLoS pathogens [PLoS Pathog] 2016 Aug 31; Vol. 12 (8), pp. e1005868. Date of Electronic Publication: 2016 Aug 31 (Print Publication: 2016).
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural
    MeSH Terms:
    Immune Evasion*
    Lymphocyte Activation*
    Cytomegalovirus/*immunology
    Cytomegalovirus Infections/*immunology
    Killer Cells, Natural/*immunology
    Animals ; Humans ; K562 Cells ; Macaca fascicularis ; Membrane Glycoproteins/immunology ; NK Cell Lectin-Like Receptor Subfamily K/immunology ; Viral Proteins/immunology
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Broadly targeted CD8⁺ T cell responses restricted by major histocompatibility complex E.
    Autorzy:
    Hansen SG; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
    Wu HL; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
    Burwitz BJ; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
    Hughes CM; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
    Hammond KB; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
    Ventura AB; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
    Reed JS; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
    Gilbride RM; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
    Ainslie E; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
    Morrow DW; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
    Ford JC; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
    Selseth AN; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
    Pathak R; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
    Malouli D; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
    Legasse AW; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
    Axthelm MK; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
    Nelson JA; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
    Gillespie GM; Nuffield Department of Medicine, University of Oxford, Oxford OX37FZ, UK.
    Walters LC; Nuffield Department of Medicine, University of Oxford, Oxford OX37FZ, UK.
    Brackenridge S; Nuffield Department of Medicine, University of Oxford, Oxford OX37FZ, UK.
    Sharpe HR; Nuffield Department of Medicine, University of Oxford, Oxford OX37FZ, UK.
    López CA; Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, NM 87545, USA.
    Früh K; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
    Korber BT; Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, NM 87545, USA. The New Mexico Consortium, Los Alamos, NM 87545, USA.
    McMichael AJ; Nuffield Department of Medicine, University of Oxford, Oxford OX37FZ, UK.
    Gnanakaran S; Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, NM 87545, USA.
    Sacha JB; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
    Picker LJ; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
    Pokaż więcej
    Źródło:
    Science (New York, N.Y.) [Science] 2016 Feb 12; Vol. 351 (6274), pp. 714-20. Date of Electronic Publication: 2016 Jan 21.
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
    MeSH Terms:
    CD8-Positive T-Lymphocytes/*immunology
    Cytomegalovirus/*immunology
    Epitopes, T-Lymphocyte/*immunology
    Histocompatibility Antigens Class I/*immunology
    Simian Immunodeficiency Virus/*immunology
    Animals ; Antigen Presentation ; Antigenic Variation ; Cytomegalovirus/genetics ; Epitopes, T-Lymphocyte/chemistry ; Genetic Vectors/genetics ; Genetic Vectors/immunology ; Histocompatibility Antigens Class I/chemistry ; Host-Pathogen Interactions/immunology ; Immune Evasion ; Killer Cells, Natural/immunology ; Macaca mulatta ; Protein Structure, Secondary ; Vaccination
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
      Wyświetlanie 1-9 z 9

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies